Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and Exchange Commission proxy filing. Compensation packages for executives ...

According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...

Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...

Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Investors need to pay close attention to Globus Medical (GMED) stock based on the movements in the options market lately.

UnitedHealth Group, Eli Lilly and Company, Novo Nordisk A/S, Elevance Health, and Johnson & Johnson are the five Medical stocks to watch today, according to MarketBeat’s stock screener tool.

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

For Globus Medical, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive ... Consensus whose definition is related ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...

events or circumstances or other factors arising or coming to our attention after the date hereof. Contacts: Investors: Globus Medical NewsMORE Related Stocks ...